MGC Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MGCD and buy or sell other stocks, ETFs, and their options commission-free!

About MGCD

MGC Diagnostics Corp. is a global medical technology company, which engages in the development, manufacture, and selling of medical products. Its products include mouthpiece, nose clip, pediatric adapter, rubber coupler, pulomonary supplies, and gas exchange supplies. 

CEO
Todd M. Austin
CEOTodd M. Austin
Employees
Employees
Headquarters
St. Paul, Minnesota
HeadquartersSt. Paul, Minnesota
Founded
1977
Founded1977
Employees
Employees

MGCD Key Statistics

Market cap
48.63M
Market cap48.63M
Price-Earnings ratio
-13.13
Price-Earnings ratio-13.13
Dividend yield
Dividend yield
Average volume
15.53K
Average volume15.53K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$11.20
52 Week high$11.20
52 Week low
$6.24
52 Week low$6.24

Stock Snapshot

With a market cap of 48.63M, MGC Diagnostics(MGCD) trades at $11.03. The stock has a price-to-earnings ratio of -13.13.

On 2026-03-13, MGC Diagnostics(MGCD) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 15.53K.

The stock's 52-week range extends from a low of $6.24 to a high of $11.20.

The stock's 52-week range extends from a low of $6.24 to a high of $11.20.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.